Date of report (Date of earliest event reported): May 20, 2021
McDONALD’S CORPORATION
(Exact Name of Registrant as Specified in Charter)
Delaware
1-5231
36-2361282
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
110 North Carpenter Street
Chicago, Illinois
(Address of Principal Executive Offices)
60607
(Zip Code)
(630) 623-3000
(Registrant’s telephone number, including area code)
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $0.01 par value
MCD
New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Item 5.07. Submission of Matters to a Vote of Security Holders.
The following is a brief description and the voting results of each proposal voted upon at the Annual Shareholders’ Meeting held on May 20, 2021 of McDonald’s Corporation (the “Company”).
Each of the twelve Directors proposed by the Company were re-elected for a one-year term beginning in May and continuing until the Company’s 2022 Annual Shareholders’ Meeting and until their successors have been elected and qualified. The votes on this proposal were as follows:
Director Name
For
Against
Abstain
Broker Non-Votes
Lloyd Dean
479,411,242
20,283,555
884,844
104,585,676
Robert Eckert
438,925,416
60,730,521
923,704
104,585,676
Catherine Engelbert
497,573,708
2,213,615
792,318
104,585,676
Margaret Georgiadis
497,617,823
2,112,848
848,970
104,585,676
Enrique Hernandez, Jr.
350,725,528
148,927,252
926,861
104,585,676
Christopher Kempczinski
490,966,120
8,721,632
891,889
104,585,676
Richard Lenny
397,145,054
102,496,941
937,646
104,585,676
John Mulligan
495,615,097
4,026,665
937,879
104,585,676
Sheila Penrose
476,623,513
23,097,162
858,966
104,585,676
John Rogers, Jr.
461,685,686
37,999,108
894,847
104,585,676
Paul Walsh
454,817,289
44,784,659
977,693
104,585,676
Miles White
412,011,127
87,646,609
921,905
104,585,676
The proposal regarding an advisory vote to approve the compensation awarded to the Company’s named executive officers for 2020 was approved. The votes on this proposal were as follows:
For
Against
Abstain
Broker Non-Votes
466,532,516
30,771,468
3,275,657
104,585,676
The proposal regarding an advisory vote to ratify the appointment of Ernst & Young LLP to serve as independent auditor for 2021 was approved. The votes on this proposal were as follows (there were no broker non-votes on this proposal):
For
Against
Abstain
578,661,134
25,376,702
1,127,481
The proposal regarding an advisory vote on a shareholder proposal requesting a report on sugar and public health was not approved. The votes on this proposal were as follows:
For
Against
Abstain
Broker Non-Votes
52,846,129
438,917,378
8,816,134
104,585,676
The proposal regarding an advisory vote on a shareholder proposal requesting a report on antibiotics and public health costs was not approved. The votes on this proposal were as follows:
For
Against
Abstain
Broker Non-Votes
56,454,152
416,462,524
27,662,965
104,585,676
The proposal regarding an advisory vote on a shareholder proposal requesting the ability for shareholders to act by written consent was not approved. The votes on this proposal were as follows:
For
Against
Abstain
Broker Non-Votes
212,252,064
285,447,888
2,879,689
104,585,676
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
McDONALD’S CORPORATION
(Registrant)
Date:
May 26, 2021
By:
/s/ Denise A. Horne
Denise A. Horne
Corporate Vice President, Associate General Counsel and Assistant Secretary